Stoke Therapeutics Inc buy Wedbush
Start price
11.07.24
/
50%
€13.00
Target price
11.07.25
€15.62
Performance (%)
-23.46%
End price
12.07.25
€9.95
Summary
This prediction ended on 12.07.25 with a price of €9.95. The prediction for Stoke Therapeutics Inc disappointed with a performance of -23.46%. Wedbush has a follow-up prediction for Stoke Therapeutics Inc where he still thinks Stoke Therapeutics Inc is a Buy. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Stoke Therapeutics Inc | 37.069% | 37.069% | 22.308% |
| iShares Core DAX® | 0.855% | 0.498% | 31.385% |
| iShares Nasdaq 100 | -1.591% | 1.232% | 13.023% |
| iShares Nikkei 225® | 0.299% | 9.734% | 8.784% |
| iShares S&P 500 | -0.197% | 1.747% | 10.012% |
Comments by Wedbush for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Wedbush gewählte maximale Laufzeit wurde überschritten
Current prediction by Wedbush for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.60
13.08.25
13.08.25
€18.84
13.08.26
13.08.26
17.65%
16:19
16:19
Stopped prediction by Wedbush for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€9.30
26.03.24
26.03.24
€15.67
26.03.25
26.03.25
-27.42%
27.03.25
27.03.25